StockGlow

Corcept Therapeutics Incorporated (0I3Q.L)

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

$113.08-0.04%
Compare 0I3Q.L with
StockGlow Score
93
Bullish
BearishBullish
1 year ago+65.7%

The outlook

Corcept Therapeutics Incorporated currently reads as bullish based on above its 50- & 200-day averages, 91% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range91% of the way from its 52-week low to high
Market cap
—
52-wk high
$122.57
52-wk low
$20.76
50-day avg
$23.44
200-day avg
$26.00
Trailing P/E
1.2

Similar stocks

0GXK.LVBG Group AB (publ)$334.50+1.67%0HKE.LAxon Enterprise, Inc.$517.56-0.57%0F4O.LLotus Bakeries NV$11,060.00-2.42%0HMZ.LW. R. Berkley Corporation$72.67-0.55%0GUO.LCTT Systems AB (publ)$121.40+0.25%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy